Real-world comparative outcomes of GLP-1 RA and semaglutide prescription among individuals with type 2 diabetes
Salvatore, M. M.; Zhang, B.; Tang, H.; Lu, Y.; Zhang, D.; Zhou, T.; Lu, Y.; Amaro, A.; Ritchie, M. D.; Chen, Y.
Show abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for type 2 diabetes (T2D) and weight management, yet their broad health impacts in real- world settings remain understudied. Using data from the All of Us Research Program (n=18,746), we conducted both intention-to-treat and per-protocol phenome-wide association studies comparing diagnoses following GLP-1 RA prescription, including semaglutide-specific analyses, to those following sodium-glucose cotransporter-2 inhibitor (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP4i) prescriptions in individuals with T2D. GLP-1 RAs were associated with reduced risks of genitourinary and dental conditions relative to comparators, while semaglutide was linked to lower risks of cardiac arrhythmia, hyperglycemia, and chronic kidney disease. However, GLP- 1 RAs were also associated with increased risks of dysthymic disorder and vitamin D deficiency. Time-to-event analyses revealed modest delays in diagnosis for key outcomes. These findings underscore differences in downstream associations across second-line T2D therapies and highlight semaglutides distinct profile. Results may inform clinical decision-making and motivate further research on effectiveness, safety, and personalized prescribing.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- ExPRSweb - An Online Repository with Polygenic Risk Scores for Common Health-related Exposures 91%
- Mendelian pathway analysis of laboratory traits reveals distinct roles for ciliary subcompartments in common disease pathogenesis 91%
- Characterization of exome variants and their metabolic impact in 6,716 American Indians from Southwest US 91%
Similar papers in this journal
- Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers 91%
- Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: an observational cohort study using the OpenSAFELY platform 91%
- Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.